BioAtla Inc. (BCAB) PT Raised to $8 at Credit Suisse
Tweet
Share
E-mailGet Alerts BCAB Hot Sheet
Price: $3.45 +2.07%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Credit Suisse analyst Tiago Fauth raised the price target on BioAtla Inc. (NASDAQ: BCAB) to $8.00 (from $4.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Tingyi Cayman Islands Holding Corp. (322:HK) (TCYMY) PT Raised to HK$11.60 at Macquarie
- Adyen NV (ADYEN:NA) (ADYYF) PT Raised to EUR1,278 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
